Digital Health technologies can make a positive difference to the outcomes of patient treatment, management and care. Improving digital services and the sharing and use of data will also save time and resources so that staff can better focus on delivering medical and social care. Examples of such technologies include data collected through smartphones. For example, the ZOE COVID Symptom Study App used during the pandemic was jointly developed by King's College London, and now has more than four million users. Other digital technologies include wearable devices which can help monitor heart rate, activity and sleep and remotely assess and help manage a wide range of conditions. For example, the £23M Innovative Medicines Initiative RADAR-CNS led by King's has pioneered their use in depression, multiple sclerosis and epilepsy. Our aim is to enable the development of new digital technologies and reduce the time it takes for these to benefit patient care. The King's Health Partner (KHP) Digital Health Hub will do this by helping researchers, health and social care staff, patients and industry to work together better. We also hope to increase the availability of such technologies nationally by offering support to enable new businesses to grow rapidly, thereby making a more immediate difference to patients' lives. Digital health technologies have lots of potential but their widespread use is limited by: - A lack of examples of how clinicians, academics, engineers, quality assurance experts, health economists, patients and end users can best work together during development - Specific gaps in training and knowledge amongst the different groups, for example: - Academic and industry technologists may have trouble understanding NHS systems and fail to engage with the end users of the technologies they are trying to develop, such as health care providers, patients and carers. They may not know about or understand the complex regulatory pathway which needs to be followed before such technologies can be used in clinical practice. - Clinical specialists may lack the appropriate technical skills such as data analyses, coding and programming languages to help them develop digital applications they think will be helpful to their patients. The KHP Digital Health Hub will help to overcome the barriers to the rapid development and use of digital technologies nationally. It will be an accessible "ecosystem" comprising specialists from different sectors working together to improve understanding and use of digital technologies and addressing the government's long-term goals for health and social care. With our partners, we will connect the digital health research community to the substantial opportunities for investment in London and our diverse and world leading healthcare research environment. We have brought together a wealth of expertise from across KHP, including King's College London and partner NHS Trusts, patients and industry collaborators, to provide support and training, and create opportunities for the acceleration of digital health across the UK. KHP includes seven mental health and physical healthcare hospitals and many community sites with ~4.8 million patient contacts each year and a combined annual turnover of more than £3.7 billion. The KHP Digital Health Hub will provide: - proven expertise, infrastructure and experience of co-creation and commercialisation - a three-way clinical, academic and industry partnership - a physical location where technology developers can work collaboratively, and - an excellent track record in training which will be offered to all our partners across the health and social care sectors. With the right support and networks in place, digital health technologies have the power to transform patient care and experiences across the UK. The knowledge and expertise is all there, and together we can make sure it is shared, translated and built upon, at every step of the way.

The first viable large scale fuel cell systems were the liquid electrolyte alkaline fuel cells developed by Francis Bacon. Until recently the entire space shuttle fleet was powered by such fuel cells. The main difficulties with these fuel cells surrounded the liquid electrolyte, which was difficult to immobilise and suffers from problems due to the formation of low solubility carbonate species. Subsequent material developments led to the introduction of proton-exchange membranes (PEMs e.g. Nafion(r)) and the development of the well-known PEMFC. Cost is a major inhibitor to commercial uptake of PEMFCs and is localised on 3 critical components: (1) Pt catalysts (loadings still high despite considerable R&D); (2) the PEMs; and (3) bipolar plate materials (there are few inexpensive materials which survive contact with Nafion, a superacid). Water balance within PEMFCs is difficult to optimise due to electro-osmotic drag. Finally, PEM-based direct methanol fuel cells (DMFCs) exhibit reduced performances due to migration of methanol to the cathode (voltage losses and wasted fuel).Recent advances in materials science and chemistry has allowed the production of membrane materials and ionomers which would allow the development of the alkaline-equivalent to PEMs. The application of these alkaline anion-exchange membranes (AAEMs) promises a quantum leap in fuel cell viability. The applicant team contains the world-leaders in the development of this innovative technology. Such fuel cells (conduction of OH- anions rather than protons) offer a number of significant advantages:(1) Catalysis of fuel cell reactions is faster under alkaline conditions than acidic conditions - indeed non-platinum catalysts perform very favourably in this environment e.g. Ag for oxygen reduction.(2) Many more materials show corrosion resistance in alkaline than in acid environments. This increases the number and chemistry of materials which can be used (including cheap, easy stamped and thin metal bipolar plate materials).(3) Non-fluorinated ionomers are feasible and promise significant membrane cost reductions.(4) Water and ionic transport within the OH-anion conducting electrolytes is favourable electroosmotic drag transports water away from the cathode (preventing flooding on the cathode, a major issue with PEMFCs and DMFCs). This process also mitigates the 'crossover' problem in DMFCs.This research programme involves the development of a suite of materials and technology necessary to implement the alkaline polymer electrolyte membrane fuel cells (APEMFC). This research will be performed by a consortium of world leading materials scientists, chemists and engineers, based at Imperial College London, Cranfield University, University of Newcastle and the University of Surrey. This team, which represents one of the best that can be assembled to undertake such research, embodies a multiscale understanding on experimental and theoretical levels of all aspects of fuel cell systems, from fundamental electrocatalysis to the stack level, including diagnostic approaches to assess those systems. The research groups have already explored some aspects of APEMFCs and this project will undertake the development of each aspect of the new technology in an integrated, multi-pronged approach whilst communicating their ongoing results to the members of a club of relevant industrial partners. The extensive opportunities for discipline hopping and international-level collaborations will be fully embraced. The overall aim is to develop membrane materials, catalysts and ionomers for APEMFCs and to construct and operate such fuel cells utilising platinum-free electrocatalysts. The proposed programme of work is adventurous: however, risks have been carefully assessed alongside suitable mitigation strategies (the high risk components promise high returns but have few dependencies). Success will lead to the U.K. pioneering a new class of clean energy conversion technology.

The first viable large scale fuel cell systems were the liquid electrolyte alkaline fuel cells developed by Francis Bacon. Until recently the entire space shuttle fleet was powered by such fuel cells. The main difficulties with these fuel cells surrounded the liquid electrolyte, which was difficult to immobilise and suffers from problems due to the formation of low solubility carbonate species. Subsequent material developments led to the introduction of proton-exchange membranes (PEMs e.g. Nafion(r)) and the development of the well-known PEMFC. Cost is a major inhibitor to commercial uptake of PEMFCs and is localised on 3 critical components: (1) Pt catalysts (loadings still high despite considerable R&D); (2) the PEMs; and (3) bipolar plate materials (there are few cheap materials which survive contact with Nafion, a superacid). Water balance within PEMFCs is difficult to optimise due to electro-osmotic drag. Finally, PEM-based direct methanol fuel cells (DMFCs) exhibit reduced performances due to migration of methanol to the cathode (voltage losses and wasted fuel).Recent advances in materials science and chemistry has allowed the production of membrane materials and ionomers which would allow the development of the alkaline-equivalent to PEMs. The application of these alkaline anion-exchange membranes (AAEMs) promises a quantum leap in fuel cell viability. The applicant team contains the world-leaders in the development of this innovative technology. Such fuel cells (conduction of OH- anions rather than protons) offer a number of significant advantages:(1) Catalysis of fuel cell reactions is faster under alkaline conditions than acidic conditions - indeed non-platinum catalysts perform very favourably in this environment e.g. Ag for oxygen reduction.(2) Many more materials show corrosion resistance in alkaline than in acid environments. This increases the number and chemistry of materials which can be used (including cheap, easy stamped and thin metal bipolar plate materials).(3) Non-fluorinated ionomers are feasible and promise significant membrane cost reductions.(4) Water and ionic transport within the OH-anion conducting electrolytes is favourable electroosmotic drag transports water away from the cathode (preventing flooding on the cathode, a major issue with PEMFCs and DMFCs). This process also mitigates the 'crossover' problem in DMFCs.This research programme involves the development of a suite of materials and technology necessary to implement the alkaline polymer electrolyte membrane fuel cells (APEMFC). This research will be performed by a consortium of world leading materials scientists, chemists and engineers, based at Imperial College London, Cranfield university, University of Newcastle and the University of Surrey. This team, which represents one of the best that can be assembled to undertake such research, embodies a multiscale understanding on experimental and theoretical levels of all aspects of fuel cell systems, from fundamental electrocatalysis to the stack level, including diagnostic approaches to assess those systems. The research groups have already explored some aspects of APEMFCs and this project will undertake the development of each aspect of the new technology in an integrated, multi-pronged approach whilst communicating their ongoing results to the members of a club of relevant industrial partners. The extensive opportunities for discipline hopping and international-level collaborations will be fully embraced. The overall aim is to develop membrane materials, catalysts and ionomers for APEMFCs and to construct and operate such fuel cells utilising platinum-free electrocatalysts. The proposed programme of work is adventurous: however, risks have been carefully assessed alongside suitable mitigation strategies (the high risk components promise high returns but have few dependencies). Success will lead to the U.K. pioneering a new class of clean energy conversion technology.

The first viable large scale fuel cell systems were the liquid electrolyte alkaline fuel cells developed by Francis Bacon. Until recently the entire space shuttle fleet was powered by such fuel cells. The main difficulties with these fuel cells surrounded the liquid electrolyte, which was difficult to immobilise and suffers from problems due to the formation of low solubility carbonate species. Subsequent material developments led to the introduction of proton-exchange membranes (PEMs e.g. Nafion(r)) and the development of the well-known PEMFC. Cost is a major inhibitor to commercial uptake of PEMFCs and is localised on 3 critical components: (1) Pt catalysts (loadings still high despite considerable R&D); (2) the PEMs; and (3) bipolar plate materials (there are few inexpensive materials which survive contact with Nafion, a superacid). Water balance within PEMFCs is difficult to optimise due to electro-osmotic drag. Finally, PEM-based direct methanol fuel cells (DMFCs) exhibit reduced performances due to migration of methanol to the cathode (voltage losses and wasted fuel).Recent advances in materials science and chemistry has allowed the production of membrane materials and ionomers which would allow the development of the alkaline-equivalent to PEMs. The application of these alkaline anion-exchange membranes (AAEMs) promises a quantum leap in fuel cell viability. The applicant team contains the world-leaders in the development of this innovative technology. Such fuel cells (conduction of OH- anions rather than protons) offer a number of significant advantages:(1) Catalysis of fuel cell reactions is faster under alkaline conditions than acidic conditions - indeed non-platinum catalysts perform very favourably in this environment e.g. Ag for oxygen reduction.(2) Many more materials show corrosion resistance in alkaline than in acid environments. This increases the number and chemistry of materials which can be used (including cheap, easy stamped and thin metal bipolar plate materials).(3) Non-fluorinated ionomers are feasible and promise significant membrane cost reductions.(4) Water and ionic transport within the OH-anion conducting electrolytes is favourable electroosmotic drag transports water away from the cathode (preventing flooding on the cathode, a major issue with PEMFCs and DMFCs). This process also mitigates the 'crossover' problem in DMFCs.This research programme involves the development of a suite of materials and technology necessary to implement the alkaline polymer electrolyte membrane fuel cells (APEMFC). This research will be performed by a consortium of world leading materials scientists, chemists and engineers, based at Imperial College London, Cranfield University, University of Newcastle and the University of Surrey. This team, which represents one of the best that can be assembled to undertake such research, embodies a multiscale understanding on experimental and theoretical levels of all aspects of fuel cell systems, from fundamental electrocatalysis to the stack level, including diagnostic approaches to assess those systems. The research groups have already explored some aspects of APEMFCs and this project will undertake the development of each aspect of the new technology in an integrated, multi-pronged approach whilst communicating their ongoing results to the members of a club of relevant industrial partners. The extensive opportunities for discipline hopping and international-level collaborations will be fully embraced. The overall aim is to develop membrane materials, catalysts and ionomers for APEMFCs and to construct and operate such fuel cells utilising platinum-free electrocatalysts. The proposed programme of work is adventurous: however, risks have been carefully assessed alongside suitable mitigation strategies (the high risk components promise high returns but have few dependencies). Success will lead to the U.K. pioneering a new class of clean energy conversion technology.

Intra-operational tissue assessment is a key enabling technology for minimally invasive surgery. Surgeons operating along a "keyhole" or similar means of access for minimally invasive surgery need to identify different structures or diseased areas, even when these all may look similar. This work is aimed at identifying the resection margin in cancer surgery, to allow the removal of a tumour together with a margin which is just enough to ensure complete cancer excision, but without unnecessary excess tissue removal. Currently, such a surgical margin is identified using a combination of the surgeon's experience, images of various kinds taken prior to the operation coupled with any visual observations, or tactile 'feel' in the scenario of open surgery, that the surgeon can make during the operation. Ultimate confirmation of the surgical margin relies on post-operative histopathology, where the removed tissue is assessed microscopically. Only then, will it be known if the removal has been successful or if further surgery and/or more aggressive post-operative treatment is required. These challenges are particularly acute in surgical removal of tumours from the rectum and some pelvic organs, where wider surgical excision is constrained by close proximity of anatomical structures with high functional importance, e.g. nerves and vasculature supplying bladder, bowel, sexual organs and lower limbs. The development of minimally invasive techniques (such as laparoscopy or operations along body ducts, such as in the rectum or colon) have removed surgical 'feel' for tissue characteristics, including assessment of surgical margin. This highlights an unmet clinical need for a quantitative, robust, reliable and evidence-based method of determining the optimal surgical margin and providing feedback to the surgeon in a way that it can be used to make decisions during the operation. Robot-Assisted Surgery (RAS) is the next development in minimally invasive surgery and has seen rapid development in treatment of a wide variety of conditions. It offers improved clinical accuracy by giving surgeons better control of instruments and providing features such as 3D visualisation. Such developments are particularly useful in confined spaces such as the pelvis and rectum. So far, RAS has found limited application in oncological surgery, mostly because current RAS systems rely almost entirely on visual feedback, and do not provide support for clinical decision making. This work aims to provide a novel function in RAS to enhance intra-operative clinical decision making. This technology would accelerate development of RAS in many types of visceral and solid-organ surgery where visual feedback is limited or inadequate to determine surgical margins reliably. This partnership brings together 4 distinct and complementary engineering groups with two clinical specialisms and is supported by two industries, an SME in the medical sensors area and a manufacturer of surgical robots. The group will focus on two principal aims: 1. to devise a microfabricated probe deployable via a standard minimally invasive surgery instrument capable of making intra-operative mechanical measurements on the tissue surface. 2. to establish data modelling methods in order to process the real-time measurement data to produce quantitative assessment of surgical margin as intra-operative feedback to the surgeon. The approach will be developed in a staged series of trials, including on ex vivo human tissue and in vivo animal models, with ultimate demonstration in a surgical environment. Through the work, the partnership expects to develop a unique and future-proof 'RAS-made-smarter' technology for applications in intra-operative identification of tumours and tumour margins and, by extension, in other surgical areas.